Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2016, Article ID 4592768, 7 pages
http://dx.doi.org/10.1155/2016/4592768
Clinical Study

Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma

1Department of Medicine, Section of Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA
2Comprehensive Cancer Center of Wake Forest University, Wake Forest School of Medicine, Winston-Salem, NC, USA
3Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA
4Department of Surgical Sciences, Center for Hypertension and Vascular Research, Wake Forest School of Medicine, Winston-Salem, NC, USA
5Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA

Received 25 July 2016; Accepted 20 September 2016

Academic Editor: Shreyaskumar Patel

Copyright © 2016 Paul D. Savage et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Paul D. Savage, James Lovato, K. Bridget Brosnihan, Antonius A. Miller, and W. Jeffrey Petty, “Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma,” Sarcoma, vol. 2016, Article ID 4592768, 7 pages, 2016. https://doi.org/10.1155/2016/4592768.